Research: New & Noteworthy

Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

Pictured: Developing T cells
Immunity Science at Memorial Sloan Kettering

A large community of Memorial Sloan Kettering researchers is pushing the limits of immunity science.

Pictured: Developing T cells
Pictured: Gabriela Chiosis
Hsp90: A Very Promising Target for Cancer Therapy

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Pictured: Gabriela Chiosis
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.

Giving Supplies a Second Life, and Making an Environmental Impact in the Process

Memorial Sloan Kettering “green” committees focus on waste reduction and energy efficiency throughout the institution while donating useful supplies to New York–area nonprofits.

Pictured: Gum ball machines
What Is Tumor Heterogeneity?

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.

Pictured: Gum ball machines
Pictured: Serge Lyashchenko
How Our New Particle Accelerator Will Make Cancer Imaging and Treatment More Precise

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.

Pictured: Serge Lyashchenko
Pictured: Christine Iacobuzio-Donahue, Eileen O’Reilly, Steven Leach, and Peter Allen
Pancreatic Cancer Research Center Takes Transformative Approach

Our new David M. Rubenstein Center for Pancreatic Cancer Research is an ambitious initiative to solve a difficult and complex disease.

Pictured: Christine Iacobuzio-Donahue, Eileen O’Reilly, Steven Leach, and Peter Allen
Pictured: Michael Berger
New Tumor Sequencing Test Will Bring Personalized Treatment Options to More Patients

A powerful diagnostic test, MSK-IMPACT™ gives our doctors an unparalleled amount of information about individual people’s cancers to guide their treatment.

Pictured: Michael Berger
Pictured: Jedd Wolchok
Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Jedd Wolchok